23 Hrs
Source:
المشهد العربي
Blood sugar devices benefit non-insulin users
A recent study has shown that continuous glucose monitoring devices, such as the Dexcom G7, help type 2 diabetes patients who are not on insulin improve their blood sugar control. Over a six-month trial, the average A1C decreased from 8.8% to 7.2% among users, compared to a reduction from 8.7% to 8% in the group receiving traditional care. Additionally, device users maintained their blood glucose levels within the target range for a longer period compared to the other group, demonstrating the effectiveness of this technology in managing blood sugar and improving patient outcomes, while highlighting the importance of discussing its use with a healthcare provider based on individual circumstances.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)